In the News June 2, 2019

Food Navigator | ‘The Prevalence of Questionable Products May Inspire a Tsunami of Class Action Litigation…’ the Regulatory Path Forward for CBD

Angela Spivey comments on why the cannabis industry should not expect immediate action by the U.S. Food and Drug Administration to allow cannabidiol in regulated products.
Media Contact
Alex Wolfe
Communications Director

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.